Investor Relations

Bryan Roberts co-founded Castlight in 2008 and has served as a director since that time. He previously served as the Chairman of our Board of Directors from 2010 until April 2017. Dr. Roberts joined Venrock, a venture capital firm, in 1997, where he currently serves as a Partner. Dr. Roberts currently serves as the Chairman of the board of directors of Achaogen, Inc. and as a director of Ironwood Pharmaceuticals, Inc., Vitae Pharmaceuticals and Zeltiq Aethetics, Inc. as well as several private companies. Dr. Roberts previously served on the board of directors of athenahealth, Inc. from 1999 to 2009, XenoPort, Inc. from 2000 to 2007 and Sirna Therapeutics, Inc. from 2003 to 2007. From 1989 to 1992, Dr. Roberts worked in the corporate finance department of Kidder, Peabody & Co., a brokerage company. Dr. Roberts received a B.A. in Chemistry from Dartmouth College and a Ph.D. in Chemistry and Chemical Biology from Harvard University

David B. Singer has served on our Board of Directors since June 2010. Mr. Singer has held various positions at Maverick Capital Ltd. or its affiliates, an investment firm, since December 2004, including Managing Partner of Maverick Capital Ventures since February 2015. Previously, Mr. Singer served as the founding President and Chief Executive Officer of three health care companies. He has also served on the board of directors of Pacific Biosciences of California, Inc. from December 2006 to May 2013, Affymetrix, Inc. from 1993 to 2008, Corcept Therapeutics Incorporated from 1998 to 2008 and Oscient Pharmaceuticals Corporation from 2004 to 2006. Mr. Singer has also served as the senior financial officer of two publicly traded companies. Mr. Singer serves on the boards of several private health care companies. Mr. Singer served as a health commissioner of San Francisco and a member of the San Francisco General Hospital Joint Conference Committee from July 2013 to January 2017. Mr. Singer holds a B.A. in History from Yale University and an M.B.A. from Stanford University.

David Ebersman has served as a director of Castlight since July 2011. Mr. Ebersman is currently CEO of Lyra Health, Inc., a health care information technology company focused on behavioral health. Previously, Mr. Ebersman served as the Chief Financial Officer of Facebook, Inc., from 2009 through 2014. Prior to joining Facebook, Mr. Ebersman served in various positions at Genentech, Inc., a biotechnology company, including as its Executive Vice President and Chief Financial Officer, Senior Vice President, Product Operations, and Vice President, Product Development. Prior to joining Genentech, Mr. Ebersman was a research analyst at Oppenheimer & Company, Inc., an investment company. Mr. Ebersman has been a member of the board of directors of SurveyMonkey, Inc. since June 2015. Mr. Ebersman holds an A.B. in International Relations and Economics from Brown University and was selected for a Henry Crown Fellowship in 2000.

Seth is President, COO and Co-Founder of OODA Health. Previous to OODA Health, Seth served as the Vice President of Sales and Alliances for Castlight Health (NYSE: CSLT), the leading healthcare navigation platform. At Castlight, Seth led the team responsible for market partnerships and key national accounts. Seth was one of the earliest employees and served on the leadership team. Seth is currently a member of Castlight’s board of directors.

Prior to Castlight, Seth was a management consultant in the healthcare practice of McKinsey & Company, having served clients in North America, Australia and Brazil. At McKinsey, Seth was a member of the healthcare payor and provider practice and a founding member of McKinsey’s Center for Healthcare Reform.

Seth earned an MBA from Harvard Business School and an MPA from Harvard Kennedy School, where he was a Baker Scholar, Mortimer Zuckerman fellow and Bill George fellow. Seth completed his undergraduate studies at Stanford University where he was a member of Phi Beta Kappa.

Maeve O’Meara has served as Executive Vice President, Product and Customer Experience since June 2018. Maeve joined the Company in 2010, and previously served as the Company’s Chief Product Officer and Senior Vice President of Products. Prior to joining the Company, Maeve was a venture capital investor at Highland Capital Partners, a venture capital firm, where she focused on investments in healthcare IT and services and the consumer internet markets. Maeve holds an M.B.A. from Stanford Graduate School of Business and a B.A. in Economics from the University of Virginia.